oday, the second hearing on Georgia House Bill 65 (Medical Cannabis) was held in Atlanta. The Medical Cannabis Working Group chaired by Rep. Allen Peake invited a Georgia doctor to tell her story about how cannabis oil has improved her 17 year old autistic son’s life.
The committee voted to move the bill forward to the House Judiciary Non-Civil Committee for further consideration.
HB-65 expands the current law (HB-1) by adding additional medical conditions for which cannabis oil (CBD/THC) can be used and for other purposes.
State Rep. Allen Peake, R-Macon, chairs the working group and wrote House Bill 65, which will be the vehicle for their recommendations.
“I thought today was very productive,” said Peake, after the meeting. The working group is a special committee formed this year to work on the complexities of getting a substance to Georgians that’s prohibited under federal law. The roughly 1,200 Georgians on the state medical cannabis registry for diagnoses like severe seizure disorders can posses a liquid made from medical cannabis, though there is no legal way to obtain it. The working group also recommended that people with medical cannabis cards from other states should be allowed to posses that liquid.
As states pass cannabis extract laws, entrepreneurs are stepping up to provide “CBD Oils”. The FDA has sent out warnings to several companies about the claims being made of their product’s healing properties. According to the FDA most of the ‘legal in all 50 state” oils contain little or no CBD (cannabidiol) and the products lack ingredient labeling. Note that there are many illegitimate product manufactures in America, the set back… it is illegal to ship across state lines. Georgia’s new law (HB-1) allows possession of certain cannabis extracts, for certain patients, if they can find a source in other states. Patients take the legal risks of shipping or bringing the extracts back to Georgia.
“WASHINGTON, DC — The Food and Drug Administration (FDA) has sent letters to several makers of cannabidiol (CBD) oils derived from hemp, telling them to stop making medical claims about their products’ ability to treat disease.
Many sellers of hemp-based cannabidiol products, who advertise their products as “legal in all 50 states” because they are derived from industrial hemp, have been making claims that their products are rich in cannabidiol (CBD) and can be used for “the diagnosis, cure, mitigation, treatment, or prevention of diseases,” according to the FDA.
The FDA, which considers CBD an “unapproved new drug,” says these companies are mis-branding the products and issuing false claims to consumers. Often these products do not even list their ingredients on the product label, the FDA added.”